BIOTECH & PHARMA

    Biotech and pharma stocks listed on the ASX.

    StageZero Life Sciences TSX SZLS oncology protocol cancer treatment biomarker testing

    StageZero Life Sciences launches updated care oncology protocol for enhanced cancer treatment

    Bausch + Lomb TSX BLCO Alfa Instruments global distributor surgical intraocular dyes

    Alfa Instruments chooses Bausch + Lomb as exclusive global distributor for its surgical intraocular dyes

    BetterLife Pharma CSE BETR LSD derivative treatment structural neural plasticity pre-clinical research lysergic acid diethylamide neurons

    BetterLife Pharma’s LSD-derivative treatment promotes structural neural plasticity in pre-clinical research

    Clearmind Medicine CSE CMND positive pre-clinical results cocaine addiction treatment psychedelic molecule MEAI

    Clearmind Medicine reveals further positive pre-clinical results for cocaine addiction treatment

    PharmaDrug CSE PHRX cGMP production lead candidate PD-001 cepharanthine-2HCL cancer covid

    PharmaDrug completes key milestone to support cGMP production of lead candidate PD-001

    Algernon Pharmaceuticals CSE AGN Ifenprodil study treatment idiopathic pulmonary fibrosis IPF chronic cough

    Algernon Pharmaceuticals to present findings of Ifenprodil study for treatment of idiopathic pulmonary fibrosis

    Optimi Health CSE OPTI Blue Serenity Canada first natural therapeutic psilocybin product health

    Optimi Health launches Blue Serenity, Canada’s first natural therapeutic psilocybin product

    Load more
    Small Caps Canadian stock market news TSX TSX-V CSE
    Small Caps is the world's largest financial news platform for information on publicly traded small cap companies.

    Small Caps and affiliated companies accept no responsibility for any claim, loss or damage as a result of information provided or its accuracy. The information provided on this site is general in nature, not financial product advice, see a financial expert before making any investment decision. Your personal objectives, financial situation or needs have not been taken into consideration. There may be a conflict of interest present with commercial arrangements with companies and/or stock held. Small Caps or an associate may receive a commission for funds raised.
    Copyright 2022 Small Caps. All rights reserved.